Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503061
Status:
COMPLETED
Last Update Posted:
2010-12-01
First Post:
2007-07-17
Brief Title:
A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Pharmaceopidemiological Study in Patients Who Use Symbicort Turbuhaler as Maintenance and Reliever Therapy Symbicort SMART Capturing Over Use and Under Use Via the General Practice Research Database
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate how common it is that patients using Symibort SMART take high average daily doses that are not considered appropriate by their physician overuse or are hospitalised due to their asthma at least partly due to underuse
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GPRD | None | None | None |